Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-24-001268

EVP, COO, Head of Commercial sold 731 shares at $29.96 ($21,901)

  • EVP, COO, Head of Commercial acquired 1,287 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Teehan Brendan EVP, COO, Head of Commercial 2024-01-06 Option exercise +1,287 31,680 D
Teehan Brendan EVP, COO, Head of Commercial 2024-01-08 Sale −731 $29.96 $21,901 30,949 D
Derivatives
Teehan Brendan EVP, COO, Head of Commercial 2024-01-06 Option exercise · Restricted Stock Units −1,287 0 D
Open-market sales · 731 sh · avg $29.96 · $21,901
Loading xslF345X05/doc4.xml…